Decadron and Embolism arterial - a phase IV clinical study of FDA data

Summary:

Embolism arterial is reported as a side effect among people who take Decadron (dexamethasone), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Oxycontin, and have Arrhythmias.

The phase IV clinical study analyzes which people have Embolism arterial when taking Decadron. It is created by eHealthMe based on reports of 46,837 people who have side effects when taking Decadron from the FDA, and is updated regularly.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.

What is Embolism arterial?

Embolism arterial (blood clot that has travelled through your arteries and become stuck) is found to be associated with 219 drugs and 411 conditions by eHealthMe. Check the latest studies of Embolism arterial.

On Jul, 11, 2026

46,837 people reported to have side effects when taking Decadron.
Among them, 18 people (0.04%) have Embolism arterial.

Among these 18 people:

How long have people been on Decadron when they have Embolism arterial? *

What is the gender of people who have Embolism arterial when taking Decadron? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Embolism arterial when taking Decadron? *

What are other drugs people take besides Decadron? *

What are other side effects people have besides Embolism arterial? *

Insomnia (sleeplessness): 8 people, 44.44%
Stress And Anxiety: 8 people, 44.44%
Osteonecrosis Of Jaw (death of bone of jaw): 8 people, 44.44%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 8 people, 44.44%
Dizziness: 8 people, 44.44%
Loss Of Consciousness: 8 people, 44.44%
Pain: 8 people, 44.44%
Diplopia (double vision): 7 people, 38.89%
Dry Eyes (lack of adequate tears): 7 people, 38.89%
Dyspnea Exertional: 7 people, 38.89%

What are the existing conditions these people have? *

Stable Angina (a constant chest pain): 7 people, 38.89%
Depression: 7 people, 38.89%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 38.89%
Arrhythmias (irregular heartbeat): 7 people, 38.89%
Blood Catecholamines Increased: 5 people, 27.78%
Oral Cancer (mouth cancer): 3 people, 16.67%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 1 person, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.56%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 5.56%
Asthma: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Decadron and have Embolism arterial?

- Check whether Embolism arterial is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Decadron:

Decadron (47,210 reports)

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Embolism arterial:

Embolism arterial (219 drugs)

Browse all the conditions that are associated with Embolism arterial:

Embolism arterial (411 conditions)

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Decadron) and Decadron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.